Preferred Name |
betrixaban |
|
Synonyms |
PRT054021 N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide BEVYXXA |
|
ID |
http://purl.bioontology.org/ontology/MESH/C543086 |
|
altLabel |
PRT054021 N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide BEVYXXA |
|
cui |
C2698385 C4490271 C2743196 |
|
HM |
D011725 D001549 |
|
Inverse of RB |
74RWP7W0J9 |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
20090825 |
|
MeSH Frequency |
86 |
|
MMR |
20170626 |
|
notation |
C543086 |
|
PA |
D065427 |
|
prefLabel |
betrixaban |
|
SC |
1 |
|
Scope Statement |
a highly potent, selective, and orally efficacious factor Xa inhibitor; structure in first source |
|
SRC |
Bioorg Med Chem Lett. 2009 Apr 15;19(8):;2179-85 |
|
TERMUI |
T756731 T000927873 T756733 T756732 |
|
TH |
NLM (2009) FDA SRS (2013) USAN (19XX) INN (19XX) NLM (2017) |
|
tui |
T109 T121 |
Create mapping